文献速递慢性肾脏病

慢性肾脏病女性乳腺癌与宫颈癌筛查的模式及预测因素

Patterns and Predictors of Screening for Breast and Cervical Cancer in Women with CKD.
PubMed 文献 · Clin J Am Soc Nephrol · 2016-12-29

该研究基于加拿大安大略省2002至2013年关联 administrative 健康数据,开展两项基于人群的队列研究,分别纳入141,326名和324,548名女性,分析不同CKD分期与年龄下乳腺癌和宫颈癌筛查的模式及预测因素。结果显示晚期CKD女性筛查率显著低于无CKD者,且年龄、合并症负担和收入水平与筛查率相关。

要点

  • 无CKD女性2年乳腺癌筛查累积发生率为61%,CKD 3a/3b期为54%,CKD 4/5期为37%,透析女性为26%。
  • 宫颈癌筛查3年累积发生率呈现类似模式。
  • 高龄、较高合并症负担和较低收入组与较低的筛查率相关。

核心结论

  • 大多数晚期CKD女性未接受乳腺癌或宫颈癌筛查。
  • 需要更好地理解患者和卫生专业人员对CKD中癌症筛查的偏好以及此类筛查的结局。

研究设计与样本

  • 两项基于人群的队列研究(乳腺癌和宫颈癌筛查),使用加拿大安大略省2002至2013年关联行政健康数据。
  • 乳腺癌筛查队列纳入141,326名女性,宫颈癌筛查队列纳入324,548名女性。

主要发现

  • 2年累积发生率:无CKD女性为61%,CKD 3a和3b期女性为54%,CKD 4和5期女性为37%,透析女性为26%。
  • 宫颈癌筛查的3年累积发生率观察到类似模式。
  • 乳腺癌和宫颈癌筛查与CKD的关联受年龄和CKD分期修饰,晚期CKD女性相比无CKD女性筛查发生率较低在较年长年龄组最为明显(P<0.001)。
  • 高龄、较高合并症负担和较低收入组与较低的筛查率相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Breast and cervical cancers are prevalent in women with CKD, but it is uncertain how often screening for these cancers should be undertaken given concerns that the benefits of screening may be fewer and the harms greater in women with CKD than in the general population. We examined patterns of breast and cervical cancer screening in women on the basis of CKD stage and age and assessed predictors of screening. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted two population-based cohort studies (breast and cervical cancer screening) from 2002 to 2013 using linked administrative health care data from Ontario, Canada. A total of 141,326 and 324,548 women were included in the breast and cervical cancer screening cohorts, respectively. RESULTS: The 2-year cumulative incidences were 61% among women without CKD, 54% for those with CKD stages 3a and 3b, 37% for those with CKD stages 4 and 5, and 26% for women on dialysis. Similar patterns were observed for the 3-year cumulative incidences of cervical cancer screening. The associations of breast and cervical cancer screening with CKD were modified by age and CKD stage, where lower incidence of screening in women with advanced CKD compared with no CKD was most pronounced in older age groups (P<0.001). Older age, higher comorbidity burden, and lower-income groups were associated with a lower rate of screening. CONCLUSIONS: Most women with advanced CKD do not receive breast or cervical cancer screening. A better understanding of patient and health professional preferences toward cancer screening in CKD is needed along with the outcomes of such screening.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Wong G, Hayward JS, McArthur E, et al. Patterns and Predictors of Screening for Breast and Cervical Cancer in Women with CKD. Clin J Am Soc Nephrol. 2016. PMID: 28034851. doi:10.2215/CJN.05990616

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。